Correlation Between BB Biotech and IShares SP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BB Biotech and IShares SP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BB Biotech and IShares SP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BB Biotech AG and iShares SP 500, you can compare the effects of market volatilities on BB Biotech and IShares SP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BB Biotech with a short position of IShares SP. Check out your portfolio center. Please also check ongoing floating volatility patterns of BB Biotech and IShares SP.

Diversification Opportunities for BB Biotech and IShares SP

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between BION and IShares is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding BB Biotech AG and iShares SP 500 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares SP 500 and BB Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BB Biotech AG are associated (or correlated) with IShares SP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares SP 500 has no effect on the direction of BB Biotech i.e., BB Biotech and IShares SP go up and down completely randomly.

Pair Corralation between BB Biotech and IShares SP

Assuming the 90 days trading horizon BB Biotech AG is expected to generate 1.44 times more return on investment than IShares SP. However, BB Biotech is 1.44 times more volatile than iShares SP 500. It trades about -0.06 of its potential returns per unit of risk. iShares SP 500 is currently generating about -0.09 per unit of risk. If you would invest  3,356  in BB Biotech AG on December 29, 2024 and sell it today you would lose (201.00) from holding BB Biotech AG or give up 5.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.41%
ValuesDaily Returns

BB Biotech AG  vs.  iShares SP 500

 Performance 
       Timeline  
BB Biotech AG 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BB Biotech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
iShares SP 500 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days iShares SP 500 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, IShares SP is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

BB Biotech and IShares SP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BB Biotech and IShares SP

The main advantage of trading using opposite BB Biotech and IShares SP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BB Biotech position performs unexpectedly, IShares SP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares SP will offset losses from the drop in IShares SP's long position.
The idea behind BB Biotech AG and iShares SP 500 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against IShares SP as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. IShares SP's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, IShares SP's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to iShares SP 500.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation